|
|
||||||||

* Research Service, Baltimore Veterans Affairs Medical Center, and Division of Rheumatology and Clinical Immunology, and
Department of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201
A strong female predominance is a well-recognized feature of human lupus. The mechanism by which sex influences disease expression and severity is not fully understood. To address this question, we used the parent-into-F1 (p
F1) model of chronic graft-vs-host disease (cGVHD) in which lupus-like humoral autoimmunity and renal disease are induced in normal F1 mice. An advantage of this model is that the pathogenic T cells driving disease (donor strain) can be studied separately from nonspecifically activated T cells (host strain). We observed that lupus-like disease using female donor and host mice (f
F cGVHD) is characterized by more severe long-term disease (glomerulonephritis) than with male donor and host (m
M cGVHD). Interestingly, differences in disease parameters could be seen at 2 wk after parental cell transfer, as evidenced by a 2- to 3-fold greater engraftment of donor CD4+ T cells in f
F cGVHD mice, which persisted throughout disease course. Enhanced engraftment of donor CD4+ T cells in f
F cGVHD mice was not due to differences in splenic homing, alloreactive precursor frequency, initial proliferation rates, or apoptotic rates, but rather to sustained high proliferation rates during wk 2 of disease compared with m
M cGVHD mice. Crossover studies (m
F, f
M) demonstrated that enhanced donor CD4+ T cell proliferation and engraftment segregate with the sex of the host. These results demonstrate that the sex of the recipient can influence the expansion of pathogenic T cells, thus increasing long-term the burden of autoreactive T cells and resulting in greater disease severity.
This article has been cited by other articles:
![]() |
U. Sela, M. Dayan, R. Hershkoviz, O. Lider, and E. Mozes A Peptide That Ameliorates Lupus Up-Regulates the Diminished Expression of Early Growth Response Factors 2 and 3 J. Immunol., February 1, 2008; 180(3): 1584 - 1591. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhao, L. C. Burkly, S. Campbell, N. Schwartz, A. Molano, A. Choudhury, R. A. Eisenberg, J. S. Michaelson, and C. Putterman TWEAK/Fn14 Interactions Are Instrumental in the Pathogenesis of Nephritis in the Chronic Graft-versus-Host Model of Systemic Lupus erythematosus J. Immunol., December 1, 2007; 179(11): 7949 - 7958. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-M. Ka, H.-K. Sytwu, D.-M. Chang, S.-L. Hsieh, P.-Y. Tsai, and A. Chen Decoy Receptor 3 Ameliorates an Autoimmune Crescentic Glomerulonephritis Model in Mice J. Am. Soc. Nephrol., September 1, 2007; 18(9): 2473 - 2485. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Grader-Beck, L. Casciola-Rosen, T. J. Lang, R. Puliaev, A. Rosen, and C. S. Via Apoptotic Splenocytes Drive the Autoimmune Response to Poly(ADP-ribose) Polymerase 1 in a Murine Model of Lupus J. Immunol., January 1, 2007; 178(1): 95 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bagavant, U. S. Deshmukh, H. Wang, T. Ly, and S. M. Fu Role for Nephritogenic T Cells in Lupus Glomerulonephritis: Progression to Renal Failure Is Accompanied by T Cell Activation and Expansion in Regional Lymph Nodes J. Immunol., December 1, 2006; 177(11): 8258 - 8265. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Barber, A. Bartolome, C. Hernandez, J. M. Flores, C. Fernandez-Arias, L. Rodriguez-Borlado, E. Hirsch, M. Wymann, D. Balomenos, and A. C. Carrera Class IB-Phosphatidylinositol 3-Kinase (PI3K) Deficiency Ameliorates IA-PI3K-Induced Systemic Lupus but Not T Cell Invasion J. Immunol., January 1, 2006; 176(1): 589 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Sela, N. Mauermann, R. Hershkoviz, H. Zinger, M. Dayan, L. Cahalon, J. P. Liu, E. Mozes, and O. Lider The Inhibition of Autoreactive T Cell Functions by a Peptide Based on the CDR1 of an Anti-DNA Autoantibody Is via TGF-{beta}-Mediated Suppression of LFA-1 and CD44 Expression and Function J. Immunol., December 1, 2005; 175(11): 7255 - 7263. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |